Income Statement (TTM)
Assurance Healthcare Limited Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2023 03-31 |
2023 06-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 6 | 7 | 8 | 9 | 8 | 8 | 8 | 8 | 8 | -1 | -2 | 0 | -0 | -1 | 1 | 1 | 1 |
Change (%) | 13.15 | 14.48 | 12.65 | -5.92 | -6.30 | 1.83 | 1.79 | 3.33 | -114.55 | 100.00 | -112.96 | -252.65 | 165.51 | -147.71 | -1.45 | -1.47 | |
% of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
Cost Of Sales | 6 | 7 | 8 | 9 | 8 | 8 | 7 | 7 | 7 | -0 | -1 | 1 | -0 | -1 | 1 | 1 | 1 |
Change (%) | 19.22 | 11.35 | 10.20 | -7.04 | -7.57 | -4.44 | -4.65 | 0.12 | -104.98 | 134.48 | -166.62 | -171.05 | 240.75 | -164.40 | 0.78 | 0.77 | |
% of Revenue | 102.75 | 108.26 | 105.30 | 103.01 | 101.79 | 100.41 | 94.22 | 88.26 | 85.51 | 29.26 | 34.30 | 176.36 | 82.09 | 105.35 | 142.22 | 145.43 | 148.73 |
Gross Operating Profit | -0 | -1 | -0 | -0 | -0 | -0 | 0 | 1 | 1 | -1 | -2 | -0 | -0 | 0 | -0 | -0 | -0 |
Change (%) | 240.20 | -26.50 | -36.05 | -44.05 | -78.74 | -1,547.69 | 106.91 | 27.50 | -171.02 | 85.74 | -84.94 | -64.19 | -179.25 | -476.70 | 6.04 | 5.70 | |
% of Revenue | -2.75 | -8.26 | -5.30 | -3.01 | -1.79 | -0.41 | 5.78 | 11.74 | 14.49 | 70.74 | 65.70 | -76.36 | 17.91 | -5.35 | -42.22 | -45.43 | -48.73 |
SG&A | -0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change (%) | -36.58 | -69.54 | -228.33 | -2.13 | -2.17 | -14.02 | -16.31 | 314.99 | -94.36 | 100.00 | 320.81 | -8.91 | -9.78 | 159.17 | -13.48 | -15.58 | |
% of Revenue | -5.13 | -2.88 | -0.77 | 0.87 | 0.91 | 0.95 | 0.80 | 0.66 | 2.64 | -1.02 | -1.02 | 33.22 | -19.83 | -6.74 | 36.60 | 32.13 | 27.53 |
R&D | |||||||||||||||||
Change (%) | |||||||||||||||||
% of Revenue | |||||||||||||||||
OpEx | 6 | 7 | 9 | 10 | 9 | 9 | 9 | 9 | 9 | 0 | 0 | 2 | 1 | -1 | 2 | 2 | 2 |
Change (%) | 22.07 | 17.98 | 15.24 | -4.24 | -4.43 | -1.30 | -1.32 | 6.84 | -94.77 | -29.58 | 541.30 | -71.44 | -250.14 | -296.15 | -0.73 | -0.73 | |
% of Revenue | 101.33 | 109.32 | 112.66 | 115.26 | 117.32 | 119.66 | 115.99 | 112.45 | 116.26 | -41.79 | -14.71 | 728.26 | -136.26 | 77.05 | 316.80 | 319.12 | 321.51 |
Operating Income | -0 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -2 | -3 | -2 | -1 | -0 | -1 | -1 | -1 |
Change (%) | 692.46 | 55.57 | 35.72 | 6.80 | 6.36 | -17.19 | -20.76 | 35.00 | 26.84 | 61.81 | -29.04 | -42.60 | -74.21 | 350.61 | -0.39 | -0.39 | |
% of Revenue | -1.33 | -9.32 | -12.66 | -15.26 | -17.32 | -19.66 | -15.99 | -12.45 | -16.26 | 141.79 | 114.71 | -628.26 | 236.26 | 22.95 | -216.80 | -219.12 | -221.51 |
Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | |||
Change (%) | -9.74 | 56.62 | 36.15 | 47.16 | 32.05 | 2.28 | 2.23 | -11.13 | -96.20 | -20.62 | 161.89 | ||||||
% of Revenue | -0.40 | -0.32 | -0.44 | -0.53 | -0.83 | -1.17 | -1.17 | -1.18 | -1.01 | -2.56 | 0.06 | -1.65 | -1.33 | -3.53 | |||
Net Income | 1 | 0 | -0 | -1 | -1 | -2 | -1 | -1 | -3 | -6 | -7 | -3 | -2 | -1 | -1 | -1 | -1 |
Change (%) | -83.72 | -376.10 | 136.22 | 101.44 | 50.36 | -26.88 | -36.76 | 194.58 | 116.52 | 23.31 | -56.87 | -28.71 | -40.27 | -12.04 | -0.18 | -0.18 | |
% of Revenue | 10.27 | 1.48 | -3.56 | -7.47 | -16.00 | -25.67 | -18.44 | -11.45 | -32.65 | 486.06 | 299.68 | -997.47 | 465.85 | 104.80 | -193.22 | -195.71 | -198.28 |
Source: Capital IQ